Trial Profile
Randomised placebo-controlled, double-blind, exploratory trial of Bosentan for Steroid-resistant Pulmonary Sarcoidosis: the BOSSA Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2019
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary sarcoidosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms BOSSA
- 16 Nov 2014 New trial record